Skip to main content
Clinical Trials/CTRI/2024/06/068271
CTRI/2024/06/068271
Not yet recruiting
Phase 2

EFFECT OF INDIVIDUALISED HOMOEOPATHIC MEDICINE ON SERUM IgE LEVELS IN CASES OF CHRONIC URTICARIA-AN OPEN LABEL CLINICAL STUDY - Nil

ational institute of homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational institute of homoeopathy
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ational institute of homoeopathy

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients clinically diagnosed as cases of chronic urticaria.
  • 2\.Patients of age group of 18\-65 years.
  • 3\.Patients of both sexes.
  • 4\.Patients are able to understand English/Bengali/Hindi
  • 5\.Patients with known but controlled systemic diseases.
  • 6\.Patients giving written consent to participate in the study.
  • 7\.Pre\-diagnosed cases of chronic urticaria with or without raised IgE level.
  • 8\.Patients who has stopped taking other medicine for chronic urticaria 2 weeks prior to treatment.

Exclusion Criteria

  • 1\)cases suffering from uncontrolled systemic illness or life threatening infections
  • 2\)patients with life threatening complications of urticaria
  • 3\)patients with malignancy of any organs
  • 4\)patients not willing to give consent for participation
  • 5\)patients who continue to be under other method of treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials